Talis Biomedical (TLIS) - 2023 Q3 - Quarterly Report
Talis Biomedical Talis Biomedical (US:TLIS)2023-11-14 13:15

UNITED STATES SECURITIES AND EXCHANGE COMMISSION For the transition period from Commission File Number: 001-40047 WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Talis Biomedical Corporation (Exact Name of Registrant as Specified in its Charter) Delaware (State or other jurisdiction ...